S Chandrasekhar Selected Research

parathyroid hormone (1-38)

9/2001	Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
5/2000	In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Chandrasekhar Research Topics

Disease

4	Bone Resorption 04/2004 - 08/2000
2	Neoplasms (Cancer) 08/2006 - 01/2001
1	Smear Layer 08/2012
1	Osteoarthritis 09/2010
1	Neoplasm Metastasis (Metastasis) 07/2001
1	Necrosis 01/2001
1	Osteoporosis 09/2000
1	Infections 06/2000
1	Osteosarcoma (Osteogenic Sarcoma) 05/2000

Drug/Important Bio-Agent (IBA)

3	OsteoprotegerinIBA 04/2004 - 08/2000
2	Parathyroid Hormone (Parathormone)IBA 04/2004 - 09/2000
2	parathyroid hormone (1-38)IBA 09/2001 - 05/2000
2	ProdrugsIBA 07/2001 - 06/2000
1	Saline SolutionIBA 08/2012
1	ChlorhexidineIBA 08/2012
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2012
1	aggrecanaseIBA 09/2010
1	Biomarkers (Surrogate Marker)IBA 09/2010
1	nimbolideIBA 08/2006
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2004
1	CalciumIBA 09/2001
1	Glycoproteins (Glycoprotein)IBA 08/2000
1	Thymidine KinaseIBA 06/2000
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2000
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2000
1	Ganciclovir (Cytovene)FDA LinkGeneric 06/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2000
1	Messenger RNA (mRNA)IBA 05/2000
1	Proteins (Proteins, Gene)FDA Link 05/2000